Clinical Research Directory
Browse clinical research sites, groups, and studies.
HIFU for Focal Ablation of Prostate Tissue: An Observational Study
Sponsor: University of California, Los Angeles
Summary
The Sonablate HIFU device was approved by the U.S.FDA for prostate tissue ablation in October, 2015. The purpose of this observational research study is to investigate the localized treatment of prostate cancer using HIFU through clinical data and health-related quality of life (HRQOL) questionnaires.
Official title: High-Intensity Focused Ultrasound for Focal Ablation of Prostate Tissue: An Observational Study of Multiparametric MRI and Ultrasound Fusion Imaging for Guidance
Key Details
Gender
MALE
Age Range
40 Years - 85 Years
Study Type
OBSERVATIONAL
Enrollment
100
Start Date
2018-09-26
Completion Date
2028-01-31
Last Updated
2025-03-13
Healthy Volunteers
No
Conditions
Interventions
Sonablate HIFU device
In this study, we will be using the Sonablate 450 HIFU System. The Sonablate HIFU device was approved by the U.S. FDA for prostate tissue ablation in October, 2015. HIFU is an example of focal therapy, where the intervention involves targeting diseased areas of prostate tissue, while preserving healthy prostate tissue and minimizing damage to surrounding structures.
Locations (1)
University of California, Los Angeles
Los Angeles, California, United States